Skip to main content
Log in

Immunomodulatory activity of protein-bound polysaccharide extracted from chelidonium majus

  • Research Articles
  • Medicinal Chemistry & Natural Products
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

In the course of searching immunomodulators from natural sources, the protein-bound polysaccharide, CM-Ala, has been isolated from the water extract ofChelidonium majus L. (Papaveraceae). The immunostimulatory characteristics have been investigated in several experiments such as generation of activated killer (AK) cells, proliferation of splenocytes, activation of macrophages and granulocyte macrophage-colony forming cell (GM-CFC) assay. Of the fractions obtained using Sephacryl S200 column chromatography, CM-Ala was the most effective fraction that augmented the cytotoxicity against Yac-1 tumor cells from 0.88% to 34.18% by culturing with splenocytes for 5 days. CM-Ala also enhanced nitric oxide production by two fold in peritoneal macrophages and exhibited antitumor activity. It showed mitogenic activity on both spleen cells and bone marrow cells. CM-Ala induced proliferation of splenocytes by 84 fold and increased GM-CFC numbers by 1.48 fold over than the non-treated. On the contrary, CM-Ala had cytotoxic activity to a diverse group of tumor cells. From the above results, we proposed that CM-Ala has a possibility of an effective antitumor immunostimulator.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal. Biochem., 72, 248–254 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Chihara, G., Hamuro, J., Maeda, Y. Y., Arai, Y., and Fukuoka, F., Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, fro.Lentinus edodes (Berk) Sing, (an Edible mushroom).Cancer Res., 30, 2776–2781 (1970).

    PubMed  CAS  Google Scholar 

  • Dimler, R. J., Schaefer, W. C., Wise, C. S., and Rist, C. E., Quantitative paper chromatography of D-glucose and its oligosaccharides.Anal. Chem., 24, 1411–1415 (1952).

    Article  CAS  Google Scholar 

  • Ghaffar, A., Cullen, R. T., and Woodruff, M.F.A., Further analysis of the anti-tumor effect in vitro of peritoneal exudate cells from mice treated wit.Corynebacterium parvum. Brit. J. Cancer, 31, 15–24 (1975).

    CAS  Google Scholar 

  • Grimm, E. A., Mazumder, A., Zhang, H. Z., and Rosenberg, S. A., Lymphokine-activated killer cell phenomenon, lysis of natural killer-resistant fresh solid tumor cells by interleikin 2- activated autologous human peripheral blood lymphocytes.J. Exp. Med., 155, 1823–1841 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Herbermann, R. B., Biological response modifiers for the treatment of cancer. In: E. Tsubura, I. Urashizaki, T. Aoki, S. Sone and Y. Kaneto. (Eds.).Rationale of Biological response Modifiers in Cancer Treatment. Excepta Medica, Princeton, pp. 240–255, (1985)

    Google Scholar 

  • Hibbs, J. B., Taintor, R. R., and Vavrin, Z., Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogrn oxidation to nitrite.Science, 235, 473–476 (1987).

    Article  PubMed  CAS  Google Scholar 

  • Hibbs, J. B., Taintor, R. R., Vavrin, Z., and Rachlin, E. M., Nitric oxide; a cytotoxic-activated macrophage effector molecule.Biochem. Bioph. Res. Co., 157, 87–94 (1988).

    Article  CAS  Google Scholar 

  • Hoshina, T. and Uchida, A., OK-432 (picibanil): Property, action and chemical effectiveness. In: T. Hoshino. (Eds.), Excepta Medica, Amsterdam, pp. 3–21, (1984).

    Google Scholar 

  • Jee, H. J. and Lee, S. I., Implication of Korean medicinal plants. Korea medical Index Inc., Seoul, pp. 153, (1988).

    Google Scholar 

  • Kery, A., Horvath, J., Nasz, I., Verzar-petri, G., Kulcsar, G., and Dan, P., Antiviral alkaloids in Chelidonium majus.Acta Pharm. Hungarica, 57, 19–25 (1987).

    CAS  Google Scholar 

  • Kim, K. H., Lee, Y S., Jung, I. S., Park, S. Y., Chung, H. Y., Lee, I. R., and Yun, Y S., Acidic polysaccharide fro.Panax ginseng, Ginsan, induces Th1 cell and macrophage cytokines and generate LAK cells in synergy with rlL-2.Planta Med., 64, 110–115 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Klimetzek, V. and Remold, H.G., The murine bone marrow macrophage, a sensitive indicator cell for murine migration inhibitory factor and a new method for their harvest.Cell. Immunol. 53, 257–266 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Lee, Y. S., Jung, I. S., Lee, I. R., Kim, K. H., Hong, W. S., and Yun, Y S., Activation of multiple effector pathway of immune system by the antineoplastic immunostimulator acidic polysaccharide Ginsan isolated fro.Panax ginseng. Anticancer Res., 17, 323–332 (1997).

    CAS  Google Scholar 

  • Lenfeld, J., Kroutil, M., Marsalek, E., Slavik, J., Preininger, V., and Simanek V., Antiinflammatory activity of quarternary benzophenanthridine alkaloids fro.Chelidonium majus. Planta Med., 43, 161–165 (1981).

    Article  CAS  Google Scholar 

  • Liepins A. and Nowicky J. W., Activation of spleen cell lytic activity by the alkaloid thiophosphoric acid derivative: ukrain.Int. J. Immunopharmaco., 14, 1437–1442 (1992).

    Article  CAS  Google Scholar 

  • Lotze, M. T., Frana, L. W., Sharrow, S. O., Robb, R. J., and Rosenberg, S. A., In vivo administration of purified human interleukin 2.1. Half-life and immunologic effects of Jurkat cell line-derived interleukin 2.J. Immunol., 134, 157–166 (1985).

    PubMed  CAS  Google Scholar 

  • Lotze, M. T., Grimm, E. A., Mazumder, A., Strausser, J. L., and Rosenberg, S. A., Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.Cancer Res., 41, 4420–4425 (1981).

    PubMed  CAS  Google Scholar 

  • Lotze, M. T., Matory, Y L., Rayner, A. A., Ettinghausen, S. E., Vetto, J. T., Seipp, C.A., and Rosenberg, S.A., Clinical effects and toxicity of interleukin 2 in patients with cancer.Cancer Res., 58, 2764–2772 (1986).

    CAS  Google Scholar 

  • Lowry, O. H., Rosenberg, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the folin phenol reagent.J. Biol. Chem., 193, 265–275 (1951).

    PubMed  CAS  Google Scholar 

  • Mule, J. J. and Rosenberg, S. A, Measurement of cytotoxic activity of LAK/NK cells. In: J.E. Coliga, A.M. Kruisbeek, D.H. Margalies, E.M. Shevach and W. Strober. (Eds.). Current protocols in immunology. John Willey and Sons, New York, pp 7.18.1–7.18.7, (1991).

    Google Scholar 

  • Rosenberg, S. A., Lotze, M. T., Muul, L. M., Leitman, S., Chang, A. E., Ettinghausen, S. E., Maltory, Y. L., Skibber, J. M., Shiloni, E., and Vetto, J. T., Observations on the systemic administraion of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.New Engl. J. Med. 313, 1485–1492 (1985).

    PubMed  CAS  Google Scholar 

  • Rosenstein, M., Yron, I., Kaufman, Y., and Rosenberg, S. A., Lymphokine-activated killer cell: Lysis of fresh syngeneic natural killerresistant murine tumor cells by lymphocytes cultured in interleukin 2.Cancer Res., 44, 1946–1953 (1984).

    PubMed  CAS  Google Scholar 

  • Song, J. Y., Yang, H. O., Park, S. Y., Pyo, S. N., Kim, K. W. Son, E. W., and Yun, Y S., Screening of antineo-plastic immuno-modulator from herbal medicines.Yakhak Hoeji, 42, 132–139 (1998).

    CAS  Google Scholar 

  • Talmadge, J. E. and Herbermann, R. B., The preclinical screening laboratory:Evaluation of immunomodulatory and therapeutic properties of biological response modifiers.Cancer Treat. Reports, 70, 171–182 (1986).

    CAS  Google Scholar 

  • Terry, W. D. and Rosenberg, S. A., Immunotherapy of Human Cancer. Elsevier North-Holland. New York, (1982).

    Google Scholar 

  • Tsukagoshi, S., Hashimoto, Y., Fujii, G., Kobayashi, H., Nomoto, K. and Orita, K., Krestin(PSK).Cancer Treat. Rev., 11, 131–155 (1984).

    Article  PubMed  CAS  Google Scholar 

  • Urba, W. J. and Longo, D. L., a-lnterferon in the treatment of modular lymphoma.Semin. Oncol., 13 (suppl. 5), 40–47 (1986).

    PubMed  CAS  Google Scholar 

  • Voltchek, I., Kamyshentsev, M., Lavinsky, Y., Nowisky, J., Medvedev, Y., and Litvinchuk, L., Comparative study of the cytostatic effects of oliphen and ukrain.J. Chemotherapy, 8, 144–146 (1996).

    CAS  Google Scholar 

  • West, W. H., Tauer, K. W., Yannelli, J. R., Marshall, G. D., Orr, D. W., Thurman, G. B., and Oldham, R. K., Constant infusion recombinant interleukin 2 in adaptive immunotherapy of advanced cancer.New Engl. J. Med., 316, 898–905 (1987).

    PubMed  CAS  Google Scholar 

  • Wimer, B. M., The ideal biological response modifier.Mol. Biotherapy, 1, 311–317 (1989).

    CAS  Google Scholar 

  • Wyczolkowska, J., Michon, T., and Nowicky, J. W., Inhibitory effect of thiophosphoric acid alkaloid derivatives from Cheli-donium majus (ukrain) on ovalbumin antigenicity and anti-ovalbumin IgE antibody response in mice.Drug. Exp. Clin. Res., 22, 225–228 (1996).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yeon-Sook Yun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Song, JY., Yang, HO., Pyo, SN. et al. Immunomodulatory activity of protein-bound polysaccharide extracted from chelidonium majus. Arch Pharm Res 25, 158–164 (2002). https://doi.org/10.1007/BF02976557

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02976557

Key words

Navigation